- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hypersensitivity, Immediate in South Africa
Total 743 results
-
AstraZenecaRecruitingAsthmaUnited States, Canada, South Africa, Korea, Republic of, Philippines, Czechia, Malaysia, Germany
-
Novartis PharmaceuticalsTerminatedAsthmaGermany, United States, Korea, Republic of, Poland, United Kingdom, Israel, Russian Federation, Italy, Turkey, Argentina, France, Hungary, Mexico, Canada, Czechia, Finland, Portugal, Romania, Slovakia, South Africa
-
GlaxoSmithKlineCompletedAsthmaUnited States, Russian Federation, Canada, Germany, Peru, Australia, Mexico, Chile, Costa Rica, Spain, Poland, Lithuania, Latvia
-
AstraZenecaParexelCompletedAsthmaUnited States, Germany, South Africa, Ukraine, Japan, Hungary, Poland, Bulgaria
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedAsthmaUnited States, Canada, Czechia, Hungary, Poland, Russian Federation, South Africa, Ukraine
-
SunovionCompleted
-
AstraZenecaCompleted
-
AstraZenecaAmgenRecruitingAsthmaUnited States, Poland, Korea, Republic of, Spain, France, China, United Kingdom, Canada, Netherlands, Argentina, Mexico, Brazil, Hungary, Japan, Philippines, South Africa, Colombia
-
GlaxoSmithKlineIqvia Pty LtdActive, not recruitingAsthmaUnited States, Japan, Poland, Spain, Italy, Australia, Taiwan, France, Hungary, Canada, Czechia
-
Boehringer IngelheimCompletedAsthmaUnited States, Australia, Canada, Colombia, Korea, Republic of, Mexico, New Zealand, Peru, Philippines, Taiwan
-
Hoffmann-La RocheCompletedAsthmaKorea, Republic of, United States, Belgium, Czechia, Germany, Peru, Bulgaria, Russian Federation, Argentina, Ukraine, Canada, Poland, South Africa, New Zealand, Romania
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
PfizerCompletedDermatitis, AtopicAustralia
-
AstraZenecaNycomed GmbHCompletedAsthmaHungary, South Africa, Russian Federation, Spain, Poland, Germany, Bulgaria, Romania, Ukraine
-
PfizerCompletedAsthmaUnited States, Canada
-
GlaxoSmithKlineCompletedAsthmaUnited States, Australia, Canada, France, Germany, Netherlands, Poland, Mexico, United Kingdom, Czech Republic
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Germany, Japan, Chile, Peru, Philippines, Poland, Mexico, Slovakia, Ukraine, South Africa, Puerto Rico, Georgia
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Australia, Germany, Poland, Romania, Russian Federation, Ukraine, Canada, Chile, France, Korea, Republic of, United Kingdom
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedAsthmaUnited States, Germany, Japan, Russian Federation, Bulgaria, Peru, Philippines, Poland, Mexico, Ukraine, Sweden, South Africa, Latvia, Puerto Rico, Georgia
-
Genentech, Inc.TerminatedModerate-to-severe Allergic AsthmaUnited States
-
SanofiActive, not recruitingDose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma (TIDE-asthma)AsthmaUnited States, Argentina, Brazil, Canada, Chile, Hungary, Italy, Japan, Korea, Republic of, Mexico, Poland, South Africa, Turkey, United Kingdom
-
AstraZenecaCompletedAsthma PatientsUnited States, Mexico, Russian Federation, South Africa, Romania, Ukraine, Japan, Argentina, Slovakia, Brazil
-
Actavis Inc.Teva Pharmaceuticals USACompleted
-
GlaxoSmithKlineCompletedAsthmaCanada, Netherlands, United States, Sweden, Russian Federation
-
UCB PharmaCompletedChronic Idiopathic UrticariaFrance, Germany, United Kingdom, Belgium, Spain, Malaysia, Romania, South Africa, Italy
-
GlaxoSmithKlineCompleted
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
GlaxoSmithKlineCompletedAsthmaUnited States, Australia, Germany, Bulgaria, Canada, Chile, France, Peru, Russian Federation, South Africa, Mexico, Estonia, Netherlands, Thailand, Poland, Czechia
-
AstraZenecaCompletedAsthmaBrazil, France, South Africa, Spain, Vietnam, Germany, Philippines, Malaysia, China, Canada, Argentina, Australia, Mexico, Thailand, Indonesia, Singapore, India
-
Boehringer IngelheimCompletedAsthmaAustria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Russian Federation, Slovakia, South Africa, Spain, Turkey, United Kingdom
-
GlaxoSmithKlineIqvia Pty LtdRecruitingAsthmaUnited States, Australia, Canada, France, Germany, Italy, Japan, Poland, Spain, China, Czechia, Hungary, Taiwan, United Kingdom
-
UCB PharmaTerminatedAsthmaItaly, Poland, United Kingdom, Germany, Spain, Belgium, South Africa, Czech Republic, Australia, France
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive | AsthmaNetherlands, Germany, Belgium, France, Canada, Italy, South Africa, Denmark
-
GlaxoSmithKlineCompletedAsthmaCanada, United States
-
GlaxoSmithKlineCompletedAsthmaUnited States, Canada, Russian Federation, Mexico, Australia, Ukraine
-
Teva Branded Pharmaceutical Products R&D, Inc.PPDCompletedAsthmaUnited States, Bulgaria, Croatia, Hungary, Israel, Poland, Serbia, Spain, Ukraine
-
SanofiRegeneron PharmaceuticalsRecruitingAsthmaBelgium, Brazil, Romania, United Kingdom, Slovakia, Hungary, Mexico, South Africa, Turkey, Greece, United States, Bulgaria, Canada, India, Ireland, Korea, Republic of, Oman, Puerto Rico, Saudi Arabia, Taiwan, United Arab Emirates
-
Novartis PharmaceuticalsCompletedAsthmaUnited States, Colombia, India, Romania, South Africa, Italy, Hungary, France, Bulgaria, Turkey, Greece, Guatemala, Japan, Argentina, Austria, Mexico, Netherlands, Peru, Poland, Russian Federation, United Kingdom, Canada
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaUnited States, Argentina, Belgium, Canada, France, Germany, Israel, Japan, Netherlands, South Africa
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
AstraZenecaCompletedAsthmaBulgaria, Czech Republic, Mexico, Poland, Russian Federation, South Africa, United Kingdom, Germany, Romania, Ukraine, Canada, Hungary, Slovakia
-
Boehringer IngelheimCompleted
-
GlaxoSmithKlineNot yet recruitingAsthmaUnited States, Argentina, Japan, Taiwan, Canada, Korea, Republic of, Australia
-
Novartis PharmaceuticalsTerminatedAsthmaGermany, Belgium, South Africa, United States, Russian Federation, France, Slovakia, Spain, Thailand, Czechia, Greece, Argentina, Peru, United Kingdom, Bulgaria, Turkey, Hungary, Vietnam, Philippines, Colombia, Chile
-
Akesobio Australia Pty LtdRecruitingPhase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic DermatitisAtopic DermatitisUnited States, Australia, New Zealand
-
SanofiRecruiting